炎症性腸疾患の位置を単一変異の解像度まで細かくマッピングする
Hailiang Huang1,2, Ming Fang3,4, Luke Jostins5,6
1Analytic and Translational Genetics Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA.
Nature
|June 29, 2017
まとめ
この研究では 炎症性腸疾患 (IBD) の 45の因果的な変異を 精密にマッピングすることで特定しました これらの発見は,IBDに関する重要な洞察を提供します.
科学分野:
- 遺伝学
- 胃腸内科
- 免疫学
背景:
- 炎症性腸疾患 (IBD) は 慢性的な胃腸疾患で 世界中の何百万人もの人に 影響しています
- 全ゲノム関連研究 (GWAS) では,多くのIBDに関連した遺伝的場所が特定されていますが,原因の多様性はほとんど解明されていません.
- IBDの遺伝的基盤を理解することは 標的治療の開発に不可欠です
研究 の 目的:
- 大規模なコホートにおけるIBDに関連した94の位置を高解像度で精密マッピングする.
- IBDの感受性を引き起こす特定の因果変異を特定する.
- 疾患メカニズムにおける特定された因果変異の機能的影響を調査する.
主な方法:
- 高密度ゲノタイプ化によるIBDロシウムの精密マッピング
- 67,852人のデータを分析して 統計力を高めました
- 高い確実性で因果変数を特定するための統計分析.
主要な成果:
- 1つの因果変異 (> 95% 確実性) に特定された18の関連と,それ以上の27の関連 (> 50% 確実性) が確認された.
- これらの45の変異は,タンパク質のコード化変化,転写因子結合部位の破壊,および組織特異的な表遺伝子マークのために強化されています.
- クローン病の免疫細胞と 潰瘍性大腸炎の 腸内粘膜の濃縮が示されました
結論:
- 大規模なコホートでの高解像度の精細マッピングは,IBDの統計的に説得力のある因果変異を効果的に特定します.
- これらの特定された変種は,IBDの病原性を明らかにするための実験的研究のための強力な基盤を提供します.
- この発見は 炎症性腸疾患の 遺伝的構造の理解を 進めているのです
さらに関連する動画
09:08Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies
Published on: June 2, 2021
2.1K
09:44Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
525
関連する概念動画
01:11Genome-wide Association Studies-GWAS
16.0K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
16.0K
01:29Pharmacogenomics: Identification of New Drug Targets
53
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
53
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
972
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
972
01:30Inflammatory Bowel Disease II: Crohn's Disease
1.4K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.4K
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
1.3K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.3K
01:05Single Nucleotide Polymorphisms-SNPs
18.8K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
18.8K